Dividend/BonusDividend

The Board has approved a proposal for a final dividend of Rs. 57 per equity share for the fiscal year.

GlaxoSmithKline Pharmaceuticals Limited logo
GlaxoSmithKline Pharmaceuticals LimitedGLAXO · Filed with the exchange

This significant payout awaits shareholder approval at the upcoming Annual General Meeting.

Investors holding shares by the designated record date will be eligible for the dividend, with payments expected to commence shortly after AGM clearance.

This directly enhances shareholder returns.

Read the original filing(PDF)

No comments yet. Be the first.

More from GlaxoSmithKline Pharmaceuticals Limited

All announcements